Pricing Log in Create free account

Cellyan Biotechnology Co., Ltd (HKPD) vs DataMeds AI, Inc (MEDS)

Cellyan Biotechnology Co., Ltd and DataMeds AI, Inc are both Medical Distribution companies. DataMeds AI, Inc is the larger, with a market value of $5.5M against $3.4M — 1.6× the size. Across the 8 metrics below, Cellyan Biotechnology Co., Ltd leads on 5 and DataMeds AI, Inc on 3.

Valuation

Metric HKPD MEDS Medical Distribution median
P/E — n/m —
P/S — 0.39 0.27
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 17.33
EV/Sales n/m 2.54 0.86
Earnings yield — (3,979.80%) (13.85%)
Free cash flow yield 0.00% (470.55%) (6.11%)

Profitability

Metric HKPD MEDS Medical Distribution median
Gross margin — (90.64%) 5.74%
Operating margin — (875.73%) 0.00%
Net margin — (1,100.29%) (11.41%)
Free cash flow margin 0.00% (182.72%) (0.36%)
Return on equity 0.00% 949.27% 0.00%
Return on assets 0.00% (202.97%) (1.95%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HKPD MEDS Medical Distribution median
Revenue growth (TTM) — (78.16%) 6.15%
EPS growth (last fiscal year) (2,521.89%) (853.33%) 5.18%
Revenue growth, 5-year CAGR — — 8.18%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric HKPD MEDS Medical Distribution median
Debt to equity 0.10 (1.01) (0.66)
Current ratio 3.86 0.14 0.99
Net debt to EBITDA (0.79) (0.30) (0.10)

Dividend

Metric HKPD MEDS Medical Distribution median
Dividend yield — 0.00% —
Payout ratio — — —

Size

Metric HKPD MEDS Medical Distribution median
Market cap 3.35m 5.48m 97.81m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack